Part of the critical coverage around “Protocols” this month — including a widely read Slate review — has raised the same underlying question: does it matter that Huberman’s platform includes extensive sponsorships and commercial partnerships, some with supplement companies whose products he then discusses favorably?
It’s a fair question, and it’s bigger than one book or one person. Every major health-content creator right now — podcaster, book author, app founder — operates with some version of this conflict, because sponsorship is how the content economics work at scale. The useful conversation isn’t “cancel Huberman” or “ignore the criticism.” It’s: what’s the actual framework for evaluating health information from anyone with a commercial stake in the answer — because that describes almost the entire category, including, frankly, some coaching businesses.
Why Sponsorship Doesn’t Automatically Mean the Science Is Wrong
It’s worth saying plainly: a financial relationship with a supplement company doesn’t automatically invalidate the underlying science. Correlation between “sponsored” and “false” isn’t 1:1. Plenty of well-evidenced protocols are also, coincidentally, sold as supplements — that’s not necessarily corruption, that’s a market responding to real demand for a real thing.
The actual risk isn’t “sponsored content is always false.” It’s more subtle: sponsorship shifts what gets emphasized, how confidently it’s stated, and what gets left out — not necessarily what’s technically claimed. A supplement with modest, mixed evidence can get presented with the same confident tone as a well-replicated intervention, and a casual audience has no way to tell the difference in tone alone.
The Framework We’d Actually Use
Whether you’re reading Huberman, any other health creator, or frankly evaluating our own claims at NGD, here’s the filter worth applying to any confidently stated health recommendation:
- Who funded or benefits from this claim, and is that disclosed? Not disqualifying on its own — but worth knowing before you weight the confidence of the claim.
- What’s the actual evidence tier? A single study, an animal model, a meta-analysis, and decades of replicated human trials are not the same thing, even when presented in the same confident sentence.
- Does the confidence level match the evidence tier? This is the single most useful tell. Confident language applied to thin evidence is the pattern to watch for — regardless of who’s saying it or who’s paying them.
- Would this recommendation survive being tested against your own data? The best filter of all — a claim that’s actually true should show up in your own tracked biometrics when you try it. One that doesn’t is worth dropping regardless of how confidently it was delivered.
Why We Built NGD Around Point 4
This is precisely why our model isn’t “trust our recommendation because we said so with confidence” — it’s track it against your own physiology and let the data adjudicate. We have no product to sell you that benefits from a specific protocol looking better than it is. Our incentive is that your tracked outcomes improve, because that’s the entire basis of the client relationship continuing. That’s a genuinely different incentive structure than a media platform whose revenue depends partly on sponsor relationships, and it’s worth being honest that it’s also different from a supplement company’s incentive structure, however well-intentioned the person representing it.
None of this means Huberman’s book is untrustworthy across the board — much of it, as we’ve written elsewhere, rests on genuinely strong evidence. It means the sponsorship critique is a useful reminder to apply the same evidence-tiering discipline to every confident health claim you encounter, including the ones we make.
Want your current protocol stack run through this exact filter, with no product to sell you at the end of it? Book a discovery call.